Privately held, Italian multinational company, with R&D, manufacturing, marketing and sales capabilities, and an extensive product portfolio mainly based on hyaluronic acid (HA) in joint care, wound healing, ophthalmology, aesthetics and autologous biological therapy. Over 55 years of R&D have placed Fidia at the forefront in the production of HA with different MWs (700+ patents). Manufacturing operations are inspected and approved by major international health authorities, and comply with the strictest regulations and safety standards. Products are available in 100+ countries worldwide, through local partners and wholly-owned subsidiaries in strategic markets. Fidia has entered the medical aesthetic market, with the aim of developing and combining innovative protocols and applications involving autologous biological treatments and proprietary HA-based products, to offer both the doctor and the patient, tailor-made solutions that preserve the person’s natural beauty and unique identity